Expect 15-18% upside in Sun Pharma over medium to long term: Hemang Jani 0 23.05.2024 09:07 Economictimes.indiatimes.com Sun Pharma numbers were slightly below expectations in terms of EBITDA and we do think that though they have guided for a very strong growth through their speciality portfolio, that is a little bit time away. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ